Genesis AI announced a $500 million Series A round on November 17, 2026, at a $3.5 billion post-money valuation. The round was co-led by Khosla Ventures, Premji Invest and Eclipse, with participation from Nvidia, AMD Ventures, Samsung Next, Ericsson, Bpifrance and individual backers including former Google CEO Eric Schmidt and former Yahoo CEO Jerry Yang, according to Genesis AI's announcement.
What is Genesis AI actually selling?
The company's product is Eno, a general-purpose humanoid robot aimed first at manufacturing, logistics and lab work, with hospitality, healthcare and outdoor tasks planned later. Co-founder and CEO Zhou Xian, alongside co-founder Théophile Gervet, built the company around a full-stack approach: Genesis designs its own hardware, trains its own foundation model called GENE, and runs its own simulation environment, Genesis World, to test behaviors before they move onto physical robots.
Zhou described the mission as removing "the physical limits on human ambition" by getting reliable robots deployed at scale rather than kept as lab demonstrations. The company says it is already testing a small number of Eno units with customers, including a partnership with South Korea's LG CNS covering manufacturing and logistics tasks, with a wider rollout targeted for 2027.
How does the glove-based training actually work?
Genesis collects motion and force data using a sensor-equipped glove worn by human operators performing ordinary tasks. The company then builds Eno's hands to mirror human hand proportions and fits them with the same sensor suite, creating what it calls a 1:1:1 mapping between a human hand, the glove and the robotic hand. In practice, that means a worker's grip pressure, finger sequencing and wrist angle while packing a box can be recorded once and replayed as training data for the robot, rather than requiring engineers to hand-code each motion.
In a demonstration shown to reporters, a Genesis robotic arm picked up two small boxes, scanned them, placed them inside a larger box, folded and taped it shut, then peeled a label from a strip of printer tape and applied it — a sequence of fine motor tasks that has historically been difficult for robots to chain together reliably.
How does Genesis stack up against Figure, Agility and the rest?
Humanoid robotics has drawn enormous capital in 2026: Agile Robots raised $500 million the same week at an $8.5 billion valuation, and Figure and Agility Robotics have each pursued separate manufacturing and logistics deals. Genesis is differentiating on hands rather than legs or mobility — betting that the harder, more valuable problem is fine manipulation, not walking. Investors appear to agree with that framing: the $3.5 billion valuation puts Genesis, a company still in early customer pilots, ahead of many robotics firms with years of shipped hardware.
What happens next?
The near-term test is whether Eno's glove-trained dexterity holds up outside controlled demos. Genesis says its initial industrial deployments with LG CNS will determine how the 2027 wider rollout is scoped. Given how much capital has now piled into dexterous-manipulation robotics in a single month, buyers in warehousing and electronics assembly are likely to see competing pilot offers from several well-funded startups before any of them reach meaningful commercial scale.